These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25644548)

  • 41. Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial.
    Tessitore N; Bedogna V; Poli A; Lipari G; Pertile P; Baggio E; Contro A; Criscenti P; Mansueto G; Lupo A
    Nephrol Dial Transplant; 2014 Jan; 29(1):179-87. PubMed ID: 24166470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive methods to identify early vascular access dysfunction.
    Soule JL; Henry ML
    Semin Vasc Surg; 2007 Sep; 20(3):164-6. PubMed ID: 17884617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring dialysis arteriovenous fistulae: it's in our hands.
    Coentrão L; Turmel-Rodrigues L
    J Vasc Access; 2013; 14(3):209-15. PubMed ID: 23599144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of AV Fistulas and AV Grafts after Interventional Stent-Graft Deployment in Haemodialysis Patients.
    Schmelter C; Raab U; Lazarus F; Ruppert V; Vorwerk D
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):878-86. PubMed ID: 25373798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence-based data for the hemodialysis access surgeon.
    Huber TS; Buhler AG; Seeger JM
    Semin Dial; 2004; 17(3):217-23. PubMed ID: 15144548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
    J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review.
    Tonelli M; James M; Wiebe N; Jindal K; Hemmelgarn B;
    Am J Kidney Dis; 2008 Apr; 51(4):630-40. PubMed ID: 18371539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing vascular access morbidity: a comparative trial of two vascular access monitoring strategies.
    Lok CE; Bhola C; Croxford R; Richardson RM
    Nephrol Dial Transplant; 2003 Jun; 18(6):1174-80. PubMed ID: 12748352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Access monitoring does not really improve outcomes.
    Paulson WD
    Blood Purif; 2005; 23(1):50-6. PubMed ID: 15627737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of timing of thrombectomy on survival of thrombosed arteriovenous hemodialysis grafts.
    Rabin I; Shani M; Mursi J; Peer A; Beberashvili I; Bass A; Feldman L
    Vasc Endovascular Surg; 2013 Jul; 47(5):342-5. PubMed ID: 23635387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
    Chen HY; Chiu YL; Chuang YF; Hsu SP; Pai MF; Lai CF; Yang JY; Peng YS; Tsai TJ; Wu KD
    Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients characteristics and outcome of 518 arteriovenous fistulas for hemodialysis in a sub-Saharan African setting.
    Fokou M; Ashuntantang G; Teyang A; Kaze F; Chichom Mefire A; Halle MP; Angwafo F; Takongmo S; Sandmann W
    Ann Vasc Surg; 2012 Jul; 26(5):674-9. PubMed ID: 22284777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrasound dilution evaluation of pediatric hemodialysis vascular access.
    Goldstein SL; Allsteadt A
    Kidney Int; 2001 Jun; 59(6):2357-60. PubMed ID: 11380840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arteriovenous access monitoring with ultrasound dilution in a pediatric hemodialysis unit.
    Ashoor IF; Hughson EA; Somers MJ
    Blood Purif; 2015; 39(1-3):93-8. PubMed ID: 25662517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation between gender and vascular access complications in hemodialysis patients.
    Astor BC; Coresh J; Powe NR; Eustace JA; Klag MJ
    Am J Kidney Dis; 2000 Dec; 36(6):1126-34. PubMed ID: 11096036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of far infrared therapy on arteriovenous fistulas in hemodialysis patients: a meta-analysis.
    Wan Q; Yang S; Li L; Chu F
    Ren Fail; 2017 Nov; 39(1):613-622. PubMed ID: 28805538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.
    Jackson RS; Sidawy AN; Amdur RL; Khetarpal A; Macsata RA
    J Vasc Surg; 2011 Dec; 54(6):1706-12. PubMed ID: 21840155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pro: Vascular access surveillance in mature fistulas: is it worthwhile?
    Tessitore N; Poli A
    Nephrol Dial Transplant; 2019 Jul; 34(7):1102-1106. PubMed ID: 30768204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular access in hemodialysis patients older than 80 years.
    Olsha O; Hijazi J; Goldin I; Shemesh D
    J Vasc Surg; 2015 Jan; 61(1):177-83. PubMed ID: 25107601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.
    Gibson KD; Gillen DL; Caps MT; Kohler TR; Sherrard DJ; Stehman-Breen CO
    J Vasc Surg; 2001 Oct; 34(4):694-700. PubMed ID: 11668326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.